Regions
MAIN/REGIONS
regions/
Regions
  1. Americas
  2. Asia & Oceania
  3. Europe
  4. Middle East & Africa
  1. Solutions
  2. Products
  3. Insights
  4. About
  5. Careers
  6. Contact Us
MAIN/search
MAIN/Solutions
Solutions/
SOLUTIONS
  • Research & Development
  • Real World Evidence
  • Commercialization
  • Safety & Regulatory Compliance
  • Technologies
LIFE SCIENCE SEGMENTS
HEALTHCARE SEGMENTS
THERAPEUTIC AREAS

Impacting People's Lives

"We strive to help improve outcomes and create a healthier, more sustainable world for people everywhere.

LEARN MORE
Harness the power to transform clinical development

Reimagine clinical development by intelligently connecting data, technology, and analytics to optimize your trials. The result? Faster decision making and reduced risk so you can deliver life-changing therapies faster.

Research & Development Overview
Research & Development Quick Links
Real World Evidence. Real Confidence. Real Results.

Generate and disseminate evidence that answers crucial clinical, regulatory and commercial questions, enabling you to drive smarter decisions and meet your stakeholder needs with confidence.

REAL WORLD EVIDENCE OVERVIEW
Real World Evidence Quick Links
See markets more clearly. Opportunities more often.

Elevate commercial models with precision and speed using AI-driven analytics and technology that illuminate hidden insights in data.

COMMERCIALIZATION OVERVIEW
Commercialization Quick Links
Service driven. Tech-enabled. Integrated compliance.

Orchestrate your success across the complete compliance lifecycle with best-in-class services and solutions for safety, regulatory, quality and medical information.

COMPLIANCE OVERVIEW
Safety & Regulatory Compliance Quick Links
Intelligence that transforms life sciences end-to-end.

When your destination is a healthier world, making intelligent connections between data, technology, and services is your roadmap.

TECHNOLOGIES OVERVIEW
Technology Quick Links
MAIN/Products
Products/
CLINICAL PRODUCTS
COMMERCIAL PRODUCTS
COMPLIANCE, SAFETY, REG PRODUCTS
REAL WORLD PRODUCTS

CASE STUDY

"Data in a Day

LEARN MORE
MAIN/Insights
Insights/
BLOGS, WHITE PAPERS & CASE STUDIES

Explore our library of insights, thought leadership, and the latest topics & trends in healthcare.

DISCOVER INSIGHTS
THE IQVIA INSTITUTE

An in-depth exploration of the global healthcare ecosystem with timely research, insightful analysis, and scientific expertise.

SEE LATEST REPORTS

INSTITUTE REPORT

"Global Trends in R&D 2024

READ MORE

EMEA Insights

"IQVIA thought leadership with a focus on EMEA.

Learn more

WHITE PAPER

"DCTs Deliver Big ROI

LEARN MORE

WHITE PAPER

"Capturing value at scale: The $4 billion RWE imperative

LEARN MORE
MAIN/About
About/
FEATURED INNOVATIONS
  • IQVIA Connected Intelligence™
  • IQVIA Healthcare-grade AI™
  • Human Data Science Cloud
  • IQVIA Innovation Hub
  • Decentralized Trials
  • Patient Experience powered by Apple
WHO WE ARE
NEWS & RESOURCES

INVESTOR RELATIONS

"Visit our investor relations site for more information.

LEARN MORE
Unlock your potential to drive healthcare forward

By making intelligent connections between your needs, our capabilities, and the healthcare ecosystem, we can help you be more agile, accelerate results, and improve patient outcomes.

LEARN MORE
IQVIA AI is Healthcare-grade AI

Building on a rich history of developing AI for healthcare, IQVIA AI connects the right data, technology, and expertise to address the unique needs of healthcare. It's what we call Healthcare-grade AI.

LEARN MORE
Your healthcare data deserves more than just a cloud.

The IQVIA Human Data Science Cloud is our unique capability designed to enable healthcare-grade analytics, tools, and data management solutions to deliver fit-for-purpose global data at scale.

LEARN MORE
Innovations make an impact when bold ideas meet powerful partnerships

The IQVIA Innovation Hub connects start-ups with the extensive IQVIA network of assets, resources, clients, and partners. Together, we can help lead the future of healthcare with the extensive IQVIA network of assets, resources, clients, and partners.

LEARN MORE
Proven, faster DCT solutions

IQVIA Decentralized Trials deliver purpose-built clinical services and technologies that engage the right patients wherever they are. Our hybrid and fully virtual solutions have been used more than any others.

LEARN MORE
IQVIA Patient Experience Solutions powered by Apple

Empowering patients to personalize their healthcare and connecting them to caregivers has the potential to change the care delivery paradigm. IQVIA and Apple are collaborating to bring this exciting future of personalized care directly to devices patients already have and use.

LEARN MORE
MAIN/Careers
Careers/
WORKING AT IQVIA

Our mission is to accelerate innovation for a healthier world. Together, we can solve customer challenges and improve patient lives.

LEARN MORE
LIFE AT IQVIA

Careers, culture and everything in between. Find out what’s going on right here, right now.

LEARN MORE

WE’RE HIRING

"Improving human health requires brave thinkers who are willing to explore new ideas and build on successes. Unleash your potential with us.

SEARCH JOBS
MAIN/Contact Us
Contact Us/
Publication
Evolución del Mercado de la Farmacia Española con datos de abril 2021
May 24, 2021
  • Locations
  • España
  • Evolución del Mercado de la Farmacia Española con datos de abril 2021
To download files you must give consent to process your personal data by clicking the "Accept" button below.

En el acumulado del año 2021 (YTD 04/2021):

Mercado Farmacéutico:

  • Decrece en valores (-1,6%) y en unidades (-2,5%), en cambio, para el MAT 04/21 crece un +1,4% en valores y un +6,8% en unidades - Incluyendo geles hidroalcohólicos, mascarillas y guantes procedentes de fabricantes que no operan en España.
  • Decrece en valores y unidades (-4,0% y –7,8% respectivamente), y también en el MAT (-2,8% y -5,9% respectivamente) - Excluyendo geles hidroalcohólicos, mascarillas y guantes procedentes de fabricantes que no operan en España.

Mercado de Medicamentos:

  • Decrece en valores y unidades (-3,5% y -7,4% respectivamente), siendo un decrecimiento más leve para el MAT (-2,7% y -6,1% respectivamente)
  • Los productos antidiabéticos es la clase ATC con mayor facturación en el mes de abril, seguido por los agentes antitrombóticos, que crecen un 14,2%.
  • Por otro lado, las categorías que acumulan mayor decrecimiento en valores en el MAT son analgésicos, productos COPD y antiasmáticos, agentes que actúan sobre el sistema renina-angiotensina y agentes modificadores de los lípidos.

Mercado de Consumer Health:

  • Decrece en valores y crece en unidades (-1,6% y +0,5% respectivamente), siendo un crecimiento del +7,5% y del +28,0% respectivamente para el MAT - Incluyendo geles hidroalcohólicos, mascarillas y guantes procedentes de fabricantes que no operan en España.
  • Decrece en valores y unidades (-13,1% y -19,5% respectivamente), presentando un decrecimiento menor en el MAT (-6,8% y -10,1% respectivamente) - Excluyendo geles hidroalcohólicos, mascarillas y guantes procedentes de fabricantes que no operan en España.
  • En el mes de abril:
    • El segmento OTC tiene una cuota de mercado del 35,5% y tras varios meses de decrecimiento, revierte su tendencia negativa. Las tres categorías con mayor facturación en el mes y que crecen a doble dígito son cuidado oftálmico, antálgicos musculares y analgésicos generales.
    • El segmento PAC tiene una cuota de mercado del 30,6% y decrece -19,3%. Para este período, las clases con más decrecimiento son las mascarillas; podemos asociar este cambio de tendencia a que son productos que están disponibles en otros canales y a que hubo un acopio de los mismos en anteriores meses.
    • El segmento PEC también decrece en valores (-12,3%). Destaca por primera vez, después de meses con tendencia negativa, que la categoría de solares presenta crecimientos en el mes de abril. También crece especialmente la categoría de productos antiseborreicos e higiene íntima. Sin embargo, productos corporales de belleza y productos específicos para el cuidado de pelo destacan por su decrecimiento.
    • El segmento NUT crece en valores (+6,5%). Las categorías que más crecen son dietas completas, sustitutos de comida y comidas energéticas para deportistas.
Contact Us